May 7 |
Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say
|
May 7 |
Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates
|
May 7 |
Heron Therapeutics GAAP EPS of -$0.02, revenue of $34.67M
|
May 7 |
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
|
May 6 |
Heron Therapeutics Q1 2024 Earnings Preview
|
May 2 |
Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline
|
Apr 30 |
Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know
|
Apr 25 |
Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Profit Outlook
|
Apr 24 |
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
|
Apr 16 |
Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain
|